Investor Relations

ImQuest Life Sciences will become a leader in the
development of exciting new drugs for unmet medical
needs throughout the world.

Investor Information

Need More Iinformation on Investor Relations?

ImQuest Life Sciences is always looking for potential investors. If you may have interest in joining the ImQuest team as an investor please contact Mr. Dan Caffoe, Chairman of the Board and CEO.

About Us

ImQuest Life Sciences is currently focusing on the following drug development programs, through the formation of alliances and partnerships as well as through exclusive world wide licensing:

Therapies for the treatment of HIV

Topical microbicides for the prevention of transmission of HIV
 and other sexually transmitted infections

Therapies for the treatment of HBV and HCV

Therapies for the treatment of cancer